← 전체 보충제 목록

엔테로코커스 파에시움

Enterococcus faecium

📑 PubMed 30편 🦠 프로바이오틱스

📚 관련 논문 (30편)

1.
The effectiveness of probiotics as an adjunct therapy in patients under mechanical ventilation: an umbrella systematic review and meta-analysis.
Food & function 2024 PMID:38771159

1. Food Funct. 2024 Jun 4;15(11):5737-5751. doi: 10.1039/d3fo04653b. The effectiveness of probiotics as an adjunct therapy in patients under mechanical ventilation: an umbrella systematic review and meta-analysis. Anvarifard P(1), Anbari M(1), Ghalichi F(2), Ghoreishi Z(3)(4), Zarezadeh M(1)(3).

2.
Network meta-analysis of probiotics, prebiotics, and synbiotics for the treatment of chronic constipation in adults.
European journal of nutrition 2024 PMID:38693449

2. Eur J Nutr. 2024 Sep;63(6):1999-2010. doi: 10.1007/s00394-024-03410-1. Epub 2024 May 2. Network meta-analysis of probiotics, prebiotics, and synbiotics for the treatment of chronic constipation in adults. Deng X(#)(1)(2)(3), Liang C(#)(1)(2)(3), Zhou L(1)(2)(3), Shang X(4), Hui X(2)(3), Hou

3.
Effects of probiotics in children with acute gastroenteritis: A systematic review and meta-analysis focusing on probiotics utilized in Japan.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2024 PMID:37956795

3. J Infect Chemother. 2024 Apr;30(4):337-342. doi: 10.1016/j.jiac.2023.11.005. Epub 2023 Nov 11. Effects of probiotics in children with acute gastroenteritis: A systematic review and meta-analysis focusing on probiotics utilized in Japan. Higuchi T(1), Furuichi M(2), Maeda N(3), Tsugawa T(4), I

4.
The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies.
European journal of clinical nutrition 2000 PMID:11114681

4. Eur J Clin Nutr. 2000 Nov;54(11):856-60. doi: 10.1038/sj.ejcn.1601104. The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies. Agerholm-Larsen L(1), Bell ML, Grunwald GK, Astrup A. Author information: (1)Research Department of Human Nu

5.
Effect of Probiotics on the Gut Microbiota After Colonoscopy: A Multicenter, Randomized, Placebo-Controlled Clinical Study.
Journal of gastroenterology and hepatology 2026 PMID:41249095

5. J Gastroenterol Hepatol. 2026 Jan;41(1):128-139. doi: 10.1111/jgh.70147. Epub 2025 Nov 17. Effect of Probiotics on the Gut Microbiota After Colonoscopy: A Multicenter, Randomized, Placebo-Controlled Clinical Study. Wei H(1)(2), Wang J(3), Xiao X(4), Xiao X(1), Tang K(5), Lv M(6), Li Y(7), Tan

6.
Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial.
Movement disorders : official journal of the Movement Disorder Society 2025 PMID:41126787

6. Mov Disord. 2025 Dec;40(12):2710-2721. doi: 10.1002/mds.70047. Epub 2025 Oct 23. Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial. Leta V(1)(2)(3), Zinzalias P(2), Batzu L(1)(2), Mandal G(4), Staunton J(2), Je

7.
Impact of Enterococcus faecium 129 BIO 3B-R on Helicobacter pylori eradication therapy side effects in adult patients: a randomized, double-blind, placebo-controlled study.
Scientific reports 2025 PMID:40890215

7. Sci Rep. 2025 Sep 1;15(1):32085. doi: 10.1038/s41598-025-15864-2. Impact of Enterococcus faecium 129 BIO 3B-R on Helicobacter pylori eradication therapy side effects in adult patients: a randomized, double-blind, placebo-controlled study. Tokunaga E(1)(2), Inoue J(3), Asaji N(1), Oyama K(1),

8.
Effects of probiotic supplementation on blood lipids ın hypercholesterolemic obese patients: a randomized, double-blind, placebo-controlled pilot trial.
Nutricion hospitalaria 2025 PMID:40066582

8. Nutr Hosp. 2025 Apr 21;42(2):253-264. doi: 10.20960/nh.05563. Effects of probiotic supplementation on blood lipids ın hypercholesterolemic obese patients: a randomized, double-blind, placebo-controlled pilot trial. [Article in English] Bulut S(1), Kabaran S(2). Author information: (1)Departm

9.
Probiotic Therapy of Gastrointestinal Symptoms During COVID-19 Infection: A Randomized, Double-Blind, Placebo-Controlled, Remote Study.
Nutrients 2024 PMID:39599756

9. Nutrients. 2024 Nov 20;16(22):3970. doi: 10.3390/nu16223970. Probiotic Therapy of Gastrointestinal Symptoms During COVID-19 Infection: A Randomized, Double-Blind, Placebo-Controlled, Remote Study. Horvath A(1)(2), Haller R(1)(2), Feldbacher N(1)(2), Habisch H(3), Žukauskaitė K(1)(4), Madl T(3

10.
Initial Study on the Impact of Probiotics on Postoperative Gastrointestinal Symptoms and Gut Microbiota after Sleeve Gastrectomy: A Placebo-Controlled Study.
Nutrients 2024 PMID:39458493

10. Nutrients. 2024 Oct 15;16(20):3498. doi: 10.3390/nu16203498. Initial Study on the Impact of Probiotics on Postoperative Gastrointestinal Symptoms and Gut Microbiota after Sleeve Gastrectomy: A Placebo-Controlled Study. Dowgiałło-Gornowicz N(1), Mysiorska D(1), Sosnowska-Turek E(2), Botulińsk

11.
Dynamic changes in the gut microbiota after bismuth quadruple therapy and high-dose dual therapy for Helicobacter pylori eradication.
Helicobacter 2024 PMID:38682268

11. Helicobacter. 2024 Mar-Apr;29(2):e13077. doi: 10.1111/hel.13077. Dynamic changes in the gut microbiota after bismuth quadruple therapy and high-dose dual therapy for Helicobacter pylori eradication. Chen J(1)(2), Zhang Y(2), Min H(1)(2), Zhi J(2), Ma S(2), Dong H(2), Yan J(3), Chi X(1)(2), Z

12.
Gut microbiology of UK care home residents: a cross-sectional analysis from a randomised controlled trial.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2023 PMID:37595801

12. Clin Microbiol Infect. 2023 Nov;29(11):1437-1442. doi: 10.1016/j.cmi.2023.08.001. Epub 2023 Aug 17. Gut microbiology of UK care home residents: a cross-sectional analysis from a randomised controlled trial. Gillespie D(1), Wootton M(2), Ray R(3), Calder PC(4), Mandy Lau TM(3), Owen-Jones E(

13.
Clinical efficacy of weight loss herbal intervention therapy and lifestyle modifications on obesity and its association with distinct gut microbiome: A randomized double-blind phase 2 study.
Frontiers in endocrinology 2023 PMID:37033234

13. Front Endocrinol (Lausanne). 2023 Mar 22;14:1054674. doi: 10.3389/fendo.2023.1054674. eCollection 2023. Clinical efficacy of weight loss herbal intervention therapy and lifestyle modifications on obesity and its association with distinct gut microbiome: A randomized double-blind phase 2 stud

14.
[The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study].
Terapevticheskii arkhiv 2022 PMID:36286741

14. Ter Arkh. 2022 Feb 15;94(2):180-187. doi: 10.26442/00403660.2022.02.201368. [The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study]. [Ar

15.
Diversity of Susceptibility to Unsaturated Fatty Acids in Enterococcus Strains and Their Synergistic Effects With Antibiotics.
Microbiology and immunology 2026 PMID:41531111

15. Microbiol Immunol. 2026 Mar;70(3):129-138. doi: 10.1111/1348-0421.70037. Epub 2026 Jan 13. Diversity of Susceptibility to Unsaturated Fatty Acids in Enterococcus Strains and Their Synergistic Effects With Antibiotics. Ohdan K(1)(2), Asada Y(2)(3), Nishihama S(2)(4), Kawada-Matsuo M(2), Shiba

16.
Synergistic combinations of antimicrobial peptides and conventional antibiotics: A strategy to delay resistance emergence in World Health Organization priority bacteria.
Pharmacological reviews 2026 PMID:41389440

44. Pharmacol Rev. 2026 Jan;78(1):100104. doi: 10.1016/j.pharmr.2025.100104. Epub 2025 Nov 12. Synergistic combinations of antimicrobial peptides and conventional antibiotics: A strategy to delay resistance emergence in World Health Organization priority bacteria. Roque-Borda CA(1), Zhang Q(2),

17.
Synergistic activity of fosfomycin combined with old and new oxazolidinones (linezolid, contezolid, delpazolid, and sutezolid) against bloodstream isolates of vancomycin-resistant Enterococcus faecium.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2026 PMID:41381796

27. Eur J Clin Microbiol Infect Dis. 2026 Mar;45(3):877-884. doi: 10.1007/s10096-025-05372-6. Epub 2025 Dec 12. Synergistic activity of fosfomycin combined with old and new oxazolidinones (linezolid, contezolid, delpazolid, and sutezolid) against bloodstream isolates of vancomycin-resistant Ente

18.
Synergistic activity of rifampicin and polymyxin B against intracellular Gram-negative ESKAPE pathogens involves bacterial membrane alterations and enhanced oxidative damages.
Antimicrobial agents and chemotherapy 2026 PMID:41312994

25. Antimicrob Agents Chemother. 2026 Jan 7;70(1):e0131925. doi: 10.1128/aac.01319-25. Epub 2025 Nov 28. Synergistic activity of rifampicin and polymyxin B against intracellular Gram-negative ESKAPE pathogens involves bacterial membrane alterations and enhanced oxidative damages. Varik V(#)(1)(

19.
Synergistic but clinically unattainable: amoxicillin/ceftriaxone combination against ampicillin-susceptible Enterococcus faecium.
The Journal of antimicrobial chemotherapy 2026 PMID:41247078

14. J Antimicrob Chemother. 2026 Jan 6;81(1):dkaf426. doi: 10.1093/jac/dkaf426. Synergistic but clinically unattainable: amoxicillin/ceftriaxone combination against ampicillin-susceptible Enterococcus faecium. Ashrin A(1), Hagenimana C(1)(2), Jacquier H(1)(2), Ourghanlian C(2)(3)(4), Pressiat C(

20.
In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria.
PloS one 2025 PMID:40911556

15. PLoS One. 2025 Sep 5;20(9):e0331440. doi: 10.1371/journal.pone.0331440. eCollection 2025. In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria. Klose M(1), Weber L(1), Bachmann HS(1). Author information: (1)Faculty of Health, Institute of P

21.
Synergistic antibacterial effects of postbiotics combined with linezolid and amikacin against nosocomial pathogens.
Frontiers in cellular and infection microbiology 2025 PMID:40895303

23. Front Cell Infect Microbiol. 2025 Aug 14;15:1616501. doi: 10.3389/fcimb.2025.1616501. eCollection 2025. Synergistic antibacterial effects of postbiotics combined with linezolid and amikacin against nosocomial pathogens. Yaprak Çolak E(1), Duran N(1). Author information: (1)Department of Med

22.
Is ampicillin plus cephalosporins a therapeutic option for Ampicillin-Susceptible Enterococcus faecium?
The Journal of antimicrobial chemotherapy 2025 PMID:40794810

13. J Antimicrob Chemother. 2025 Oct 3;80(10):2622-2629. doi: 10.1093/jac/dkaf226. Is ampicillin plus cephalosporins a therapeutic option for Ampicillin-Susceptible Enterococcus faecium? Bierge P(1)(2), Gómez-Sánchez I(1)(2), Garcia de la Mària C(3), Sánchez-Osuna M(1)(2), Capilla S(4), Casabell

23.
Galangin synergistically revives the antibacterial activity of vancomycin against vancomycin-resistant Enterococcus faecium.
Journal of applied microbiology 2025 PMID:39779294

21. J Appl Microbiol. 2025 Jan 6;136(1):lxaf011. doi: 10.1093/jambio/lxaf011. Galangin synergistically revives the antibacterial activity of vancomycin against vancomycin-resistant Enterococcus faecium. Ayamuang IO(1), Teethaisong Y(2), Sirichaiwetchakoon K(3), Suknasang S(4), Watthana S(1), Cha

24.
The effect of combinations of a glyphosate-based herbicide with various clinically used antibiotics on phenotypic traits of Gram-negative species from the ESKAPEE group.
Scientific reports 2024 PMID:39251613

47. Sci Rep. 2024 Sep 9;14(1):21006. doi: 10.1038/s41598-024-68968-6. The effect of combinations of a glyphosate-based herbicide with various clinically used antibiotics on phenotypic traits of Gram-negative species from the ESKAPEE group. Zerrouki H(1)(2), Hamieh A(1)(2), Hadjadj L(1)(2), Rolai

25.
Probiotic Supplementation for Treatment of Helicobacter pylori Infection: A Double-Blind Randomized Clinical Trial.
The Korean journal of helicobacter and upper gastrointestinal research 2023 PMID:40503379

12. Korean J Helicobacter Up Gastrointest Res. 2023 Mar;23(1):34-41. doi: 10.7704/kjhugr.2022.0051. Epub 2023 Feb 27. Probiotic Supplementation for Treatment of Helicobacter pylori Infection: A Double-Blind Randomized Clinical Trial. Lim NR(1), Choi SY(1), Chung WC(1). Author information: (1)De

26.
Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Trial.
Journal of neurogastroenterology and motility 2022 PMID:36250371

37. J Neurogastroenterol Motil. 2022 Oct 30;28(4):642-654. doi: 10.5056/jnm21202. Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Tri

27.
Evaluation of probiotic strains for development of fermented Alisma canaliculatum and their effects on broiler chickens.
Poultry science 2012 PMID:23155022

38. Poult Sci. 2012 Dec;91(12):3121-31. doi: 10.3382/ps.2012-02333. Evaluation of probiotic strains for development of fermented Alisma canaliculatum and their effects on broiler chickens. Hossain ME(1), Ko SY, Kim GM, Firman JD, Yang CJ. Author information: (1)Department of Animal Science and T

28.
Novel probiotic Enterococcus faecium IS-27526 supplementation increased total salivary sIgA level and bodyweight of pre-school children: a pilot study.
Anaerobe 2011 PMID:21763445

13. Anaerobe. 2011 Dec;17(6):496-500. doi: 10.1016/j.anaerobe.2011.06.003. Epub 2011 Jul 5. Novel probiotic Enterococcus faecium IS-27526 supplementation increased total salivary sIgA level and bodyweight of pre-school children: a pilot study. Surono IS(1), Koestomo FP, Novitasari N, Zakaria FR,

29.
A comprehensive review of post-market clinical studies performed in adults with an Asian probiotic formulation.
Beneficial microbes 2010 PMID:21840798

2. Benef Microbes. 2010 Mar;1(1):93-106. doi: 10.3920/BM2008.1005. A comprehensive review of post-market clinical studies performed in adults with an Asian probiotic formulation. Tompkins TA(1), Xu X, Ahmarani J. Author information: (1)Institut Rosell-Lallemand Inc., Montreal, Quebec, Canada. t

30.
[The effects of probiotics on symptoms of irritable bowel syndrome].
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2006 PMID:16809947

45. Korean J Gastroenterol. 2006 Jun;47(6):413-9. [The effects of probiotics on symptoms of irritable bowel syndrome]. [Article in Korean] Kim YG(1), Moon JT, Lee KM, Chon NR, Park H. Author information: (1)Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. B

⚠️ 면책 고지

이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.